Free access to complementary therapies for Lancaster and Morecambe cancer patients to continue into 2027

The future of free access to touch therapies has been guaranteed for cancer patients and their carers into next year.

The service, which is part-funded by Rosemere Cancer Foundation in partnership with University Hospitals of Morecambe Bay NHS Foundation Trust and CancerCare, enables cancer patients and their carers to undergo aromatherapy and other massage at no cost during their treatment.

The charity, which has helped fund all hospital-based treatments alongside the trust since 2014, has agreed to pay £24,511.67 to continue the delivery of 12 half-day massage sessions a week that are spread across Furness General Hospital, Westmorland General Hospital and the Royal Lancaster Infirmary.

This money, which includes a £1,000 donation to Rosemere Cancer Foundation by South Lakeland grant making charity The Roselands Trusts, goes towards paying for the specially trained CancerCare therapists, who

The future of complementary therapy is now guaranteed for cancer patients and their carers into 2027.placeholder image
The future of complementary therapy is now guaranteed for cancer patients and their carers into 2027.

undertake all the massages.

A half-day session enables a therapist to treat three patients/carers. For patients and carers who prefer a non-hospital setting for their massage, the same therapists offer treatments at CancerCare centres in Lancaster, Kendal, Barrow and Morecambe, with the costs covered by CancerCare.

Fiona Macdonald, lead cancer nurse for the University Hospitals of Morecambe Bay NHS Foundation Trust, said: “Complementary therapies appear to be beneficial in reducing side effects and raising the quality of life of

cancer patients.

“The service evaluates positively with patients and is well received by the nursing and medical teams. An all-party parliamentary group for integrated healthcare recommended in 2018 that every cancer patient and their families should be offered complementary therapies as part of their treatment package to support them in their cancer journey.”

CancerCare’s latest report on patient/carer feedback on treatments delivered between April and September 2025 shows that 100% rated their massage as either benefiting them greatly (45%) or a lot (55%) with 82% rating their experience of CancerCare as excellent and 18% good.

Among those treated, an overwhelming 100% said they would recommend the service to others.

Dan Hill, Rosemere Cancer Foundation’s chief officer and head of charities for Lancashire Teaching Hospitals NHS Foundation Trust, which manages Rosemere Cancer Centre, the region’s specialist cancer treatment and

radiotherapy centre at the Royal Preston Hospital, said: “We are delighted to continue funding massage treatments, which are obviously greatly valued by those patients and carers, who take up the offer of complementary therapy.

“We are also extremely grateful to The Roselands Trust for its support in helping us fund treatments into 2027.”

Dan added: “This is a no waiting list service to which patients and their families can self-refer. My message to anyone eligible is to take advantage of it by at least giving complementary therapy a go. Its benefits are proven and

the feedback that existing patients and carers give to the CancerCare therapists delivering treatments couldn’t be better. It is high praise indeed.”

Rosemere Cancer Foundation works to bring world class cancer treatments and services to cancer patients from throughout south Cumbria and Lancashire being treated not only at Rosemere Cancer Centre but also at

another eight hospital cancer units across the two counties, including at the Royal Lancaster Infirmary, Furness and Westmorland General Hospitals.

The charity funds cutting edge equipment, research, training and other cancer services and therapies such as complementary therapies that the NHS is unable to afford.

For more information, visit www.rosemere.org.uk

News you can trust since 1837
Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice